Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,508,296
Closed -$619M 43
2020
Q4
$619M Sell
1,508,296
-665,548
-31% -$277M 2.25% 22
2020
Q3
$900M Sell
2,173,844
-250,180
-10% -$101M 3.86% 10
2020
Q2
$940M Buy
2,424,024
+259,953
+12% +$97.3M 4.75% 7
2020
Q1
$680M Buy
2,164,071
+691,296
+47% +$233M 4.03% 9
2019
Q4
$540M Sell
1,472,775
-115,968
-7% -$36.8M 2.86% 17
2019
Q3
$406M Buy
+1,588,743
New +$445M 2.39% 24
2017
Q2
Sell
-1,184,119
Closed -$244M 40
2017
Q1
$244M Buy
+1,184,119
New +$245M 1.28% 29
2015
Q1
Sell
-1,911,536
Closed -$275M 58
2014
Q4
$275M Sell
1,911,536
-262,586
-12% -$35.9M 1.15% 29
2014
Q3
$283M Buy
+2,174,122
New +$276M 1.11% 35

Other funds holding HUM

Lone Pine Capital's HUM Position: Q1 2021 in Review

Lone Pine Capital sold out of Humana (HUM) in Q1 2021, closing a stake of 1,508,296 shares — an estimated $619M sold.

Lone Pine Capital first reported a position in HUM in Q3 2014 and held it in 9 quarters. The position peaked at $940M in Q2 2020. 876 funds tracked by Wall St. Rank hold HUM as of Q1 2021.

  • Lone Pine Capital reported no remaining Humana position as of Q1 2021 after selling out during the quarter.
  • Lone Pine Capital sold 1,508,296 Humana shares in Q1 2021, an estimated $619M.
  • Lone Pine Capital first reported a position in Humana in Q3 2014 and held it in 9 quarters.
  • Lone Pine Capital's Humana position peaked at $940M in Q2 2020.
  • 876 funds tracked by Wall St. Rank held Humana as of Q1 2021.

Based on Lone Pine Capital's 13F filing for Q1 2021, filed 18 May 2021.